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continuous X-ray imaging. Spongostan standard gelatin sponge
(Johnson and Johnson Medical, Skipton, UK) was cut into small
blocks (< 1 cm diameter), suspended in a saline solution with
heparin and injected into the uterine arteries with an
immediate and marked reduction in uterine blood flow.
Following the procedure, a single dose of 50 mg methotrexate
was given intramuscularly.
Three days after embolisation the patient experienced mild
suprapubic pain with a haemorrhagic vaginal discharge. An
ultrasound examination performed on the fourth day showed
an absent gestational sac with only a thickened endocervical
epithelium. On discharge from hospital the patient received
contraception in the form of depo-medroxyprogesterone
acetate 150 mg intramuscularly.
Two weeks later she presented again with acute pain just
below the umbilicus. She acknowledged having had coitus
during these 2 weeks. Her temperature was 37.5°C, pulse rate
100/minute, blood pressure 119/63 mmHg and respiratory rate
28/minute. The lower abdomen was tender on palpation
without guarding. Excitation tenderness of the cervix was
present on vaginal examination, but the cervix itself was closed
and of normal size. The adnexae were moderately tender on
both sides.
An ultrasound examination revealed a normal cervix
without other pathology in the pelvis. Analysis of her blood
gases revealed a mild respiratory alkalosis with the carbon
dioxide pressure (pCO2) 26 mmHg, oxygen pressure (pO2) 95
mmHg and pH 7.5. Her haemoglobin value was 10.6 g/dl with
a leucocytosis of 14.9 x 109/l. The human chorionic
gonadotropin (HCG) level had decreased from 39 to less than
10 mIU/l.
The patient was admitted with the clinical diagnosis of
pelvic inflammatory disease (PID) and treated with
clindamycin intravenously. The next day she improved
significantly and on the second day she was discharged from
hospital on oral clindamycin.
Discussion
There are different treatment options when a cervical
pregnancy is diagnosed. Surgical evacuation is no longer the
first line of treatment since it is impossible to remove the
trophoblast completely. Medical treatment with methotrexate is
the current first option in the management of a cervical
pregnancy, with a 94% success rate.5 An important
contraindication is acute haemorrhage which is present in
about 30% of cases.6 The remaining treatment options include
abdominal hysterectomy, endocervical tamponade and uterine
artery embolisation. Although embolisation results in acute
hypoxia of the uterus, collateral blood supplies will restore
normal blood flow within 5 - 6 weeks. Due to the hypoxia,
methotrexate should be given before embolisation if the two
methods are applied together.
Methotrexate is not the ideal first line treatment in HIV-
positive patients as it suppresses immunity in patients who are
already immune compromised. Our patient, with a normal
CD4 count of 530 x 109/l, received methotrexate before her HIV
status was known and she developed pelvic inflammatory
disease afterwards. Owing to the risk of infection,
immunosuppressants should be limited in patients with a CD4
count of more than 200 x 109/l.
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Changes in the patient population attending a primary health
care clinic in rural South Africa between 1991 and 2001
To the Editor: Serosurveys in the last decade indicate that the
prevalence of HIV infection has risen in Hlabisa district,
KwaZulu-Natal, from 4% in 1992, to 14% in 1995 and 35% in
2002.1,2 The impact of the HIV epidemic on the patient
population attending local hospitals has been reported
previously.3 In particular, there has been a marked increase in
admissions for tuberculosis and other HIV-associated
conditions. However, there are few data on the impact of the
epidemic on the burden of illness seen at primary health clinic
level. Furthermore, in 1996, primary health care became free for
all in South Africa, whereas previously patients paid a nominal
fee to see clinic staff. The impact of this change on the
attendance at primary care clinics is unknown. Such
information is needed for planning effective responses aimed
at reducing unnecessary referrals and admissions to hospital
and to enable more effective deployment of health care
workers.
To investigate possible changes in the patient population
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attending a rural primary health clinic we reviewed a
proportion of the records of patients attending Inhlwathi clinic
in Hlabisa district, KwaZulu-Natal, in 1991 and in 2001. The
clinic, situated about 250 km north of Durban and 60 km from
the nearest paved road, is staffed by nurses and is one of 15
clinics in the district. No other health care facilities have been
opened or closed within 30 km and staffing levels within the
clinic have not changed. Between 1991 and 1996 the population
of Hlabisa district is estimated to have grown at a rate of 2.6%
per year and was about 220 000 in 1996.4 Clinic registers,
completed by nurses for every patient consultation, were
examined in more detail for July 1991 and 2001. The month of
July was chosen as it is not affected by seasonal fluctuations in
epidemic diseases such as malaria, cholera and dysentery.
Details of the patients' age, sex and presenting syndrome were
recorded.
The total number of patient consultations at the clinic was
9 969 in 1991 and 18 723 in 2001. This 88% increase in clinic
attendance is comparable to the 81% increase in admissions
(from 6 562 to 11 872) to the local hospital between 1991 and
1998 reported elsewhere.3 The number of patient consultations
in July was 836 in 1991 and 1 546 in 2001. The increase was
evident in all age groups, and for most but not all presenting
complaints. The proportion of men attending the clinic for the
month of July was stable at 33% (N = 273) in 1991, and 33%
(N = 513) in 2001. Respiratory symptoms were the most
frequently reported reasons for attendance both in July 1991
(18%, 149/836) and in 2001 (28%, 438/1 546), but the number of
patients seen with these symptoms increased threefold over
that time. There has also been an increase in attendance for
family planning services (41 people in July 1991 and 146 in July
2001) and a corresponding decrease in attendance for antenatal
care (141 in July 1991 and 96 in July 2001). Over the same time
period there has been a campaign in KwaZulu-Natal to educate
the population with regard to family planning, and injectable
contraceptives have become more widely available. 
Although it is not possible in these data to separate the
effects of the HIV epidemic from other factors impacting on
health-seeking behaviour in the community served by this
rural clinic, measures need to be taken to manage the growing
demand for health care services and to determine who needs
referral and who can be treated at the primary health clinic
level. 
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